New Key Statistics Module, Z-Score and F-Score
OTCPK:CANSF Key Ratios
| Market Cap $ M | 10.70 |
| Enterprise Value $ M | 10.98 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 8.22 |
| Price/Sales | 16.45 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.06 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 54.60 |
| 5-y EBITDA Growth Rate % | 51.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.40 |
| EV-to-EBITDA | -1.67 |
| PEG | -- |
| Shares Outstanding M | 127.22 |
| Net Margin (%) | -1,118.76 |
| Operating Margin % | -1,169.34 |
| Pre-tax Margin (%) | -1,119.07 |
| Quick Ratio | 1.29 |
| Current Ratio | 1.42 |
| ROA % (ttm) | -119.32 |
| ROE % (ttm) | -172.56 |
| ROIC % (ttm) | -299.03 |
| Dividend Yield % | -- |
| Altman Z-Score | -42.34 |
CANSF Number of Guru Trades
CANSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CANSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CANSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Willow Biosciences Inc Insider Transactions
No Available Data
News about OTCPK:CANSF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers